PHOTO
United Arab Emirates, Dubai: The Dubai Health Authority (DHA) held a workshop with the private sector to receive their input and feedback prior to developing a “Certificate of Need” policies and guidelines.
The workshop took place during the Dubai Healthcare Investors’ Forum that was held today at Hyatt Regency, Creek Hotel and was supported by Advention Business Partners and Taylor Wessing.
The CON guidelines will help further bolster the health sector and promote need-based investments so that there is equilibrium in the sector and to avoid imbalances in supply and demand in health services. The move also aims to provide patients with access to a wide range of medical specialties.
Last year, DHA launched a comprehensive Health Investment Guide, which provides in-depth details of demand, supply (which includes future supply) and gaps in the health sector.
The investment guide helps promote investment in need-based areas and supports investors. Now, adding a CON guidelines and policies will provide further clarity to investors and help them invest in areas of priority and need.
HE Humaid Al Qutami, Director General of the DHA said during the opening of the forum, “There is no doubt that the healthcare sector in Dubai is now one of the fastest growing sectors. This is due to the promising and diverse opportunities available in Dubai and incentives provided by the Government of Dubai. Dubai’s notable capabilities have transformed the city into the preferred destination for healthcare investment by multinational health organizations. We are proud of our leadership and appreciate their role in the development of the health sector. The CON Programme has policies and guidelines that ensure investments in the healthcare are in line with the requirements of the sector and the needs of the population. CON is an important tool utilized by internationally advanced healthcare systems, to link the granting of licenses for medical facilities with a CON based on accurate and transparent studies. This helps lead to a dynamic health system that offers a wide spectrum of specialized health services.”
Dr Marwan Al Mulla, CEO of Health Regulation at the DHA highlighted the growth of the health sector over the last few years. He said that currently there are 37 hospitals in the Emirate and nine are under construction.
Fatima Abbas, CEO of Strategy and Corporate Development at the DHA said, “The CON programme will support and guide investments with the right caliber to deliver quality services. Through this programme we will make investors aware of where the opportunities are, and will provide incentives in areas where investment needs exist and where CON requirements are met. his will limit oversupply of specialized services and protect investors who have invested significantly into specialized services.”
Dr. Ibtesam Al Bastaki, Director, Investments & PPPs (public-private partnership at the DHA said, “We believe that the CON programme will enable and ensure stability and sustainability of quality of care being provided for complex medical services. Investments generated through the CON programme will also lead to improvement in coverage for undersupplied services. We will work closely with the private sector to implement these guidelines and policies with an aim to further help develop the sector, keeping access to specialised services and patient experience as priority.”
The workshop was attended by several private sector entities including TVM Capital, Foundation Holdings, Mubadala, Mediclinic, Aster DM Healthcare, NMC, Imperial College of Diabetes-Abu Dhabi, American Hospital, Saudi German Hospital, Amana Healthcare, Al Zahra Hospital, HSBC-Healthcare Credit Division, Philips Healthcare, Fakeeh University Hospital, GST healthcare , Priory, Moorfields Eye Hospital, Kings Hospital London, Ashmore Group, AXA, Aetna, Cigna, Health at Hand, International Modern Hospital, Vamed, Right Health Clinics, Maudsley NHS, Medsol, Mednet, Avivo Group, Valient Clinics-Meraas Healthcare, representatives from the US Embassy in UAE, UK Business and Investment, Amanat Healthcare Investment, , Dubai FDI, Allianz Orient Insurance, Nextcare, Gulf Healthcare International, Oman Insurance and Daman Healthcare.
-Ends-
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
